Mitochondrial signals to nucleus regulate estrogen-induced cell growth

Area of Science:

• Cell Biology
• Molecular Biology
• Endocrinology

Background:

• Estrogen receptors mediate cell proliferation via genomic and non-genomic pathways.
• Mitochondria are increasingly recognized as targets of estrogen action.
• Mitochondria generate reactive oxygen species (ROS), influencing cellular signaling.

Purpose of the Study:

• To investigate the role of mitochondrial signals in estrogen-induced cell cycle progression.
• To explore the contribution of mitochondrial ROS to estrogen signaling pathways.
• To identify novel therapeutic targets for estrogen-dependent diseases.

Main Methods:

• Investigated estrogen's influence on mitochondrial oxidative phosphorylation and gene transcription.
• Analyzed the generation of ROS by estrogen within mitochondria.
• Examined the effects of antioxidants on estrogen-induced cell growth.
• Identified targets of estrogen and ROS, including kinases (A-Raf, Akt, PKC) and transcription factors (AP-1, NF-kappaB, CREB).

Main Results:

• Estrogen influences mitochondrial function and generates ROS.
• Antioxidants inhibit estrogen-induced cell growth, implicating ROS.
• Estrogen-induced mitochondrial ROS activate redox-sensitive kinases (A-Raf, Akt, PKC).
• Activated kinases signal through the MEK/ERK pathway to activate transcription factors (NF-kappaB, CREB, AP-1).

Conclusions:

• Mitochondrial ROS play a critical role in mediating estrogen-induced cell cycle progression.
• Estrogen signaling involves a novel pathway where mitochondrial ROS activate nuclear transcription factors.
• This pathway presents new therapeutic targets for estrogen-dependent cancers and diseases.